Search research articles
Contact Us
Filters
Showing results (841-850 of 931) with videos related to
Page
of 94
Sort By:
European Journal of Preventive Cardiology
|
April 1, 2021
EAPC Core Curriculum for Preventive Cardiology
Matthias Wilhelm, Ana Abreu, Paolo Emilio Adami, et al.
Frontiers in Immunology
|
February 13, 2024
Evolutionary and functional characterization of lagomorph guanylate-binding proteins: a story of gain and loss and shedding light on expression, localization and innate immunity-related functions
Luca Schelle, João Vasco Côrte-Real, Sharmeen Fayyaz, et al.
European Journal of Cardiovascular Nursing
|
June 2, 2017
Challenges in secondary prevention after acute myocardial infarction: A call for action
Massimo F Piepoli, Ugo Corrà, Paul Dendale, et al.
European Journal of Preventive Cardiology
|
September 8, 2016
Challenges in secondary prevention after acute myocardial infarction: A call for action
Massimo F Piepoli, Ugo Corrà, Paul Dendale, et al.
Autopsy & Case Reports
|
August 3, 2019
Uterine cavity embryonal rhabdomyosarcoma
Marina Gomes Pereira Sardinha, Fábio Morozetti Ramajo, Cesar Cilento Ponce, et al.
The Journal of Experimental Medicine
|
September 2, 2022
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine
Ujunwa Cynthia Okoye-Okafor, Komal K Javarappa, Dimitrios Tsallos, et al.
Thrombosis Journal
|
May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
Alexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Thrombosis Journal
|
June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
Alexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
The Lancet. Haematology
|
December 8, 2023
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
Amer M Zeidan, Kiyoshi Ando, Odile Rauzy, et al.
Nature Medicine
|
March 8, 2019
Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity
Olof S Dallner, Jill M Marinis, Yi-Hsueh Lu, et al.
Page
of 94
Search research articles
Search
Showing results (841-850 of 931) with videos related to
Sort By:
Page
of 94
European Journal of Preventive Cardiology
|
April 1, 2021
EAPC Core Curriculum for Preventive Cardiology
Matthias Wilhelm, Ana Abreu, Paolo Emilio Adami, et al.
Frontiers in Immunology
|
February 13, 2024
Evolutionary and functional characterization of lagomorph guanylate-binding proteins: a story of gain and loss and shedding light on expression, localization and innate immunity-related functions
Luca Schelle, João Vasco Côrte-Real, Sharmeen Fayyaz, et al.
European Journal of Cardiovascular Nursing
|
June 2, 2017
Challenges in secondary prevention after acute myocardial infarction: A call for action
Massimo F Piepoli, Ugo Corrà, Paul Dendale, et al.
European Journal of Preventive Cardiology
|
September 8, 2016
Challenges in secondary prevention after acute myocardial infarction: A call for action
Massimo F Piepoli, Ugo Corrà, Paul Dendale, et al.
Autopsy & Case Reports
|
August 3, 2019
Uterine cavity embryonal rhabdomyosarcoma
Marina Gomes Pereira Sardinha, Fábio Morozetti Ramajo, Cesar Cilento Ponce, et al.
The Journal of Experimental Medicine
|
September 2, 2022
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine
Ujunwa Cynthia Okoye-Okafor, Komal K Javarappa, Dimitrios Tsallos, et al.
Thrombosis Journal
|
May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
Alexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Thrombosis Journal
|
June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
Alexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
The Lancet. Haematology
|
December 8, 2023
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
Amer M Zeidan, Kiyoshi Ando, Odile Rauzy, et al.
Nature Medicine
|
March 8, 2019
Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity
Olof S Dallner, Jill M Marinis, Yi-Hsueh Lu, et al.
Page
of 94